MIST News and Press, Milestone Pharmaceuticals Inc. From 03/06/20

– Topline data from Phase 3 NODE-301 trial of etripamil in patients with PSVT expected this month –   MONTREAL and CHARLOTTE, N.C. , March 6, 2020 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the devel...

Gainers: ADMS   +14.9% . SALT   +7.7% . MGI   +3.6% . ADMA   +3.5% . AKAM   +3.2% . More news on: Adamas Pharmaceuticals, Inc., Scorpio Bulkers Inc., MoneyGram International, Inc., Stocks on the move, , , News on ETFs Read more ...

InsiderInsights' Daily Round Up articles rate the "Significance" of the Top 10 dollar value insider purchases and sales filed at the SEC on the Title date. Dollar value is only the most basic metric to assess the "Significance" of an insider transaction, however, and often not even the most im...

The following slide deck was published by Milestone Pharmaceuticals Inc. in conjunction with this Read more ...

MONTREAL and CHARLOTTE, N.C. , Nov. 14, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST) today announced that Joseph G. Oliveto , President and Chief Executive Officer, will present at the following investor conferences: The Jefferies 2019 London Healthcare Co...

Milestone Pharmaceuticals (NASDAQ: MIST ): Q3 GAAP EPS of -$0.52  misses by $0.06 . More news on: Milestone Pharmaceuticals Inc., Earnings news and commentary, Healthcare stocks news, Read more ...

– NODE-301 topline data readout expected in mid-1H20 – – Richard Pasternak , M.D. appointed to the Company's Board of Directors – MONTREAL and CHARLOTTE, N.C. , Nov. 13, 2019 /PRNewswire/ -- Milestone Pharmaceuticals Inc. (Nasdaq: MIST), a Pha...

Our weekend preview of upcoming IPOs, earnings reports, conference presentations, investor days, IPO lockup expirations, FDA decisions, Barron's mentions and other key events that could impact stocks, and our single stock focus. If you are interested in listening to Stocks To Watch ...

Welcome to Seeking Alpha's Stocks to Watch - a preview of key events scheduled for the next week. Follow this account and turn the e-mail alert on to receive this article in your inbox every Saturday morning. A podcast of Stocks to Watch is also available on Sundays on Seeking Alpha , Apple ...

Milestone Pharmaceuticals (NASDAQ: MIST ) announces that the first patient has been enrolled in the Phase 3 NODE-303 study. More news on: Milestone Pharmaceuticals Inc., Healthcare stocks news, Read more ...